Lone atrial fibrillation associated with creatine monohydrate supplementation

Ryan T Kammer1

  • 1Department of Pharmacy, Moses H. Cone Memorial Hospital, Greensboro, NC 27401, USA.

Pharmacotherapy
|May 19, 2005
PubMed

Insights

Young patients with atrial fibrillation (AF) should be screened for creatine supplement use. This case highlights creatine monohydrate as a potential reversible cause of AF in individuals without structural heart disease.

Area of Science:

  • Cardiology
  • Pharmacology
  • Sports Medicine

Background:

  • Atrial fibrillation (AF) in young adults without structural heart disease is uncommon.
  • Identifying and addressing reversible causes is crucial for managing AF in this demographic.
  • Common reversible causes include thyroid disorders, stimulant use, and alcohol intoxication.

Observation:

  • A 30-year-old male presented with rapid ventricular response atrial fibrillation.
  • Initial workup for common causes (thyroid, drug screen, alcohol) was negative.
  • Further questioning revealed the patient's use of creatine monohydrate supplements.

Findings:

  • Creatine monohydrate, a popular supplement for athletes and vegetarians, was identified as a potential trigger for AF.
  • Anecdotal reports have previously suggested a link between creatine and arrhythmias.
  • The patient's AF resolved after discontinuation of creatine and appropriate medical management.

Implications:

  • Clinicians should inquire about herbal product and dietary supplement use, including creatine, in patients presenting with AF.
  • Increased awareness and reporting of adverse effects from commonly used supplements are necessary.
  • This case underscores the importance of a comprehensive patient history to uncover less common causes of cardiac arrhythmias.

Related Concept Videos

Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective response...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...